Cite
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma
MLA
Lucía Gandullo-Sánchez, et al. “Altered ProTGFα/Cleaved TGFα Ratios Offer New Therapeutic Strategies in Renal Carcinoma.” Journal of Experimental & Clinical Cancer Research, vol. 40, no. 1, Aug. 2021, pp. 1–13. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8826f30d9f6607df97541200c91adfd7&authtype=sso&custid=ns315887.
APA
Lucía Gandullo-Sánchez, Inés Romero-Pérez, Sara García-Alonso, Juan Carlos Montero, Alberto Ocaña, Atanasio Pandiella, & Luis Chinchilla. (2021). Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma. Journal of Experimental & Clinical Cancer Research, 40(1), 1–13.
Chicago
Lucía Gandullo-Sánchez, Inés Romero-Pérez, Sara García-Alonso, Juan Carlos Montero, Alberto Ocaña, Atanasio Pandiella, and Luis Chinchilla. 2021. “Altered ProTGFα/Cleaved TGFα Ratios Offer New Therapeutic Strategies in Renal Carcinoma.” Journal of Experimental & Clinical Cancer Research 40 (1): 1–13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8826f30d9f6607df97541200c91adfd7&authtype=sso&custid=ns315887.